# abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Financial Services / Capital Markets. Price $18.12, market value $556 million.

## Valuation
- **P/E (trailing): 2.7×** (5-yr avg 6.7×, 3-yr avg 6.7×). abrdn Life Sciences Investors Shares of Beneficial Interest trades at 2.7× trailing earnings, well below its own five-year average of 6.7×: cheap by its own standards. The Financial Services median in the September 2026 study was 13.1×.
- **Price / sales: 6.4×**. Each dollar of revenue is priced at 6.4×.
- **Price / book: 1.0×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: 5.7%** (5-yr avg 7.3%). Free cash flow equals 5.7% of the market value, below its five-year average of 7.3%, so the shares are pricier on cash than usual. Above 5% is generally attractive.
- **Earnings yield: 36.6%**. The inverse of the P/E: 36.6% of the price is earned each year.

## Profitability
- **Net margin: 99.1%**. 99.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 16.7%**. 16.7% on shareholders' equity is solid.
- **Return on assets: 16.6%**. Each dollar of assets produces 16.6% of profit; low single digits are normal for banks and insurers.

## Growth
- **Revenue growth (1 yr): -0.3%**. Revenue fell 0.3% over the last year.
- **EPS growth (1 yr): -8.2%**. Earnings per share fell 8.2%, slower than revenue, so margins compressed.

## Financial health
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 12.36%** ($1.91 per share, trailing). abrdn Life Sciences Investors Shares of Beneficial Interest yields 12.36%, high enough to check carefully: yields this high often precede a cut.
- **Payout ratio: 37%** (100% of free cash flow). 37% of earnings goes out as dividends, leaving room to keep raising it.
- **Dividend growth (5 yr): 3.1%/yr** (1-yr -2.2%). The dividend has grown 3.1% a year over five years.

## Price and momentum
- **Total return (1 yr): 11.4%** (YTD 14.3%, 3-mo -6.7%). The shares are up 11.4% over twelve months including dividends.
- **From 52-week high: -20.1%** (15.7% above the low). Trading 20% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 0.80** (volatility 24%). Beta of 0.80 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=HQL · Page: https://foliofundamentals.com/stocks/hql

Not investment advice.